KRCC Co., Ltd.

KRCC Co., Ltd. started as SK Chemical's C-14 labeled compound synthesis business team in 1989 and supplied C-14 labeled compounds to Sekisui Medical, Japan, and became independent from SK Chemicals in 2001. We continued our business as Korea RadioChemical Center and changed the company name as KRCC Co., Ltd. in 2017, and transferred C-14 labeled compound synthesis business to Curachem Co., Ltd. in 2018. KRCC Co., Ltd. is now doing comprehensive new drug development business that helps domestic pharmaceutical companies and venture companies related to new drug development KRCC Co., Ltd. is agent of domestic and overseas CROs such as preclinical in vitro study, in vivo study, metabolites biotransformation, RI compound synthesis, toxicity, and comprehensive consulting for new drug development.